Abstract
dc:description.abstract<i>Tbx1</i>, a gene encoding a T-box transcription factor, is required for embryonic development in humans and mice. Half dosage of this gene causes most of the features of the DiGeorge or Velocardiofacial syndrome phenotypes, including aortic arch and cardiac outflow tract abnormalities. Here we show that genetic ablation of <i>Trp53</i> or pharmacological inhibition of its protein product p53 rescues almost completely aortic arch defects and significantly ameliorates outflow tract defects of <i>Tbx1</i> mouse mutants. <i>Trp53</i> deletion rescues the cell proliferation deficit in the second heart field of <i>Tbx1</i> mutants. In addition, and surprisingly, Tbx1 and p53 proteins can be found on neighboring sites on chromatin, suggesting that they share a set of target genes. In a search for shared targets, we found that the expression of <i>Gbx2</i>, a gene that interacts with <i>Tbx1</i> during development of the aortic arch arteries, is down regulated by <i>Tbx1</i> heterozygosity and rescued by <i>Trp53</i> heterozygosity. In addition, Tbx1 and p53 occupy the <i>Gbx2</i> gene, indicating that both contribute to its regulation. <br></br><br></br>Overall our data identify unexpected interactions between <i>Tbx1</i> and <i>Trp53</i> and provide a proof of principle that developmental defects associated with reduced dosage of <i>Tbx1</i> can be rescued pharmacologically.
Degree
thesis:*- Name dc:type.qualificationname
- phd
- Level dc:type.qualificationlevel
- doctoral
- Grantor dc:publisher.institution
- The Open University
- Year dc:date.issued
- 2014
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Caprio, Cinzia
Rights
- Language dc:language
- en